Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Appointed director

AVROBIO, Inc. (AVRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/24/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/14/2023 144 Form 144 - Report of proposed sale of securities:
07/12/2023 8-K Quarterly results
07/03/2023 4 Ostrowski Erik (Interim CEO, President and CFO) has filed a Form 4 on AVROBIO, Inc.
Txns: Granted 70,000 restricted stock units @ $0
06/12/2023 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Departure of Directors or...
Docs: "Unaudited pro forma condensed combined financial information of AVROBIO, Inc. (giving effect to the Asset Sale) as of and for the three months ended March 31, 2023 and for the year ended December 31, 2022 and the notes related thereto",
"AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million"
06/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/08/2023 4 PAIGE CHRISTOPHER (Director) has filed a Form 4 on AVROBIO, Inc.
Txns: Granted 17,643 options to buy @ $1.09, valued at $19.2k
06/08/2023 4 Donenberg Phillip B. (Director) has filed a Form 4 on AVROBIO, Inc.
Txns: Granted 17,643 options to buy @ $1.09, valued at $19.2k
06/08/2023 4 Vickers Philip J. (Director) has filed a Form 4 on AVROBIO, Inc.
Txns: Granted 17,643 options to buy @ $1.09, valued at $19.2k
06/08/2023 4 Farfel Gail M (Director) has filed a Form 4 on AVROBIO, Inc.
Txns: Granted 17,643 options to buy @ $1.09, valued at $19.2k
06/08/2023 4 Booth Bruce (Director) has filed a Form 4 on AVROBIO, Inc.
Txns: Granted 17,643 options to buy @ $1.09, valued at $19.2k
06/08/2023 4 Jenkins Annalisa (Director) has filed a Form 4 on AVROBIO, Inc.
Txns: Granted 17,643 options to buy @ $1.09, valued at $19.2k
06/08/2023 4 CLARK IAN T (Director) has filed a Form 4 on AVROBIO, Inc.
Txns: Granted 17,643 options to buy @ $1.09, valued at $19.2k
06/07/2023 144 Form 144 - Report of proposed sale of securities:
06/06/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 6.1% stake in AVROBIO, Inc.
05/25/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/18/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26 th Annual Meeting",
"AVROBIO, Inc. slide presentation"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update"
05/05/2023 ARS Form ARS - Annual Report to Security Holders:
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/01/2023 8-K Quarterly results
03/23/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/23/2023 10-K Annual Report for the period ended December 31, 2022
03/23/2023 8-K Quarterly results
Docs: "AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update"
02/27/2023 8-K Other Events  Interactive Data
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy